JAMDA
February 6, 2022
Showing 1 - 10 of 2641 results
Policy Snapshot
January 21, 2022
CMS Releases Latest Report on Antipsychotic Medication Use
The National Partnership to Improve Dementia Care in Nursing Homes has released its Antipsychotic Medicare Use and Data report for the second quarter of 2021. The Centers for Medicare & Medicaid Services (CMS) is tracking the progress of the National Partnership by reviewing publicly reported measures....
Policy Snapshot
March 20, 2026
OIG Flags Inappropriate Antipsychotic Use in Nursing Homes
A new report from the Department of Health and Human Services Office of Inspector General (OIG) found that some nursing homes inappropriately administered antipsychotic drugs to residents with dementia, exposing them to serious health risks. Based on 40 focused inspections conducted by the Centers for Medi...
JAMDA
June 2, 2022
Impact of Nursing Home Factors on Antipsychotic Use in Residents Before and After the Implementation of the Antipsychotic Reduction Initiative: A Facility-level Analysis
JAMDA
November 21, 2018
Educating Nursing Home Staff in Dementia Sensitive Communication: Impact on Antipsychotic Medication Use
An educational program to enhance communication in nursing home dementia care increased person-centered communication by staff and resulted in reduced resident behavioral symptoms measured as resistiveness to care. The purpose of this analysis was to evaluate effects on resident antipsychotic medication us...
JAMDA
January 10, 2025
Effects of Nursing Home Changes in Antipsychotic Use on Outcomes among Residents with Dementia
Little information exists on whether nationwide efforts to reduce antipsychotic use among nursing home (NH) residents with Alzheimer's disease and related dementias improved mortality and hospitalization outcomes for residents. Our objective was to examine the effect of NH decreases in antipsychotic u...
JAMDA
June 9, 2020
Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia
Following the 2012 launch of the National Partnership to Improve Dementia Care in Nursing Homes (the National Partnership), the use of antipsychotics has declined. However, little is known about the impact of this effort on quality of care and outcomes for nursing home (NH) residents with Alzheimer's ...
JAMDA
January 5, 2016
Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia
To explore antipsychotic (AP) medications and physical restraint use and their effects on physical function and cognition in older nursing home residents.
JAMDA
February 27, 2016
Antipsychotic Drug Use Is Not Associated With Long-Term Mortality Risk in Norwegian Nursing Home Patients
To assess the long-term mortality risk associated with antipsychotic drug (AP) use in nursing homes.
JAMDA
February 7, 2025
Effects of Visitation Restriction on Antipsychotic Drug Use among Nursing Home Residents with ADRD during the COVID-19 Pandemic
To estimate the immediate and long-term effects of a visitor restriction policy on antipsychotic use in nursing home (NH) residents with Alzheimer's disease and related dementias (ADRD) during COVID-19.
